Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis. Cancer investigation Wagner, M. J., Pollack, S. M., Cranmer, L. D., Thompson, M. J., Maxwell, S. n., Wright, S. n., Khaki, A. R., Madeleine, M. M., Grivas, P. n., Kuderer, N. M., Lyman, G. H., Loggers, E. T. 2021: 1–11

Abstract

Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24-69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6-41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20-62 days for pts who died. All three pts with WBC differential data (2 died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.

View details for DOI 10.1080/07357907.2021.1903914

View details for PubMedID 33720792